Bryan Poltilove, General Manager, Cell Therapy, BioSciences Division, Thermo Fisher Scientific
Waltham, MA
(NYSE: TMO)
Thermo Fisher Scientific is the world leader in serving science which uniquely positions the company to partner with customers to provide end-to-end cell therapy solutions. Thermo Fisher Scientific understands that cell therapy is a dynamic industry with rapidly evolving technologies and processes and are committed to helping cell therapy customers transition from discovery to clinical research and commercial manufacturing. Thermo Fisher Scientific’s portfolio of trusted and recognized products and services combined with over 50 years of cell culture knowledge and experience allows the company to provide comprehensive solutions to support every step of the cell therapy process – from cell collection through manufacture to clinical site delivery. Through Thermo Scientific, Applied BioSystems, Invitrogen, Fisher Scientific, Fisher BioServices, Unity Lab Services, and Gibco Cell Therapy Systems (CTS) brands, the company offers an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.
www.thermofisher.com
